Home HOMEPAGE   Sun, 08/09/2020 GMT + 7
    Q & A   Site map Forum   Site map Sitemap   E-mali Contact   Vietnamese Vietnamese
IMPE-QN
Web Sites & Commerce News - Events
Web Sites & Commerce Introduction
Web Sites & Commerce Collaborative activities
Web Sites & Commerce Training
Web Sites & Commerce Specific research studies
Web Sites & Commerce Publications
Web Sites & Commerce Mass organization activities
Web Sites & Commerce Legal documents
Web Sites & Commerce Statistical data
Web Sites & Commerce Work safety
Web Sites & Commerce Vietnam`s Physicians
Finance & Retail Malariology
Epidemiology
Malaria parasitology
Entomology
Diagnosis and Treament
Antimalarial drugs and drug resistant parasites
Malaria Vaccines
Health education and communication
Molecular - biology
Web Sites & Commerce Helminthology
Web Sites & Commerce Other vector-borne diseases

SEARCH

LOGIN
Username
Password

WEBLINKS
Other links

Visiting users: 144
4 2 1 0 0 2 7 9
Online
1 4 4
 Malariology Malaria Vaccines
Anti-malaria vaccine in sight, claim researchers

New Delhi: Researchers have claimed that they are very close to developing an anti-malaria vaccine. Almost 15,000 African children are participating in the phase three trials for the initiative.

 

Two-year-old Philip Ouma is getting a shot that could transform the fight against malaria. He is o­ne of the 15,000 African children participating in the phase three trial of a vaccine called Rts,s. Thirty years in development, it is the farthest any malaria vaccine candidate has ever gone. Researchers at trial site in Kenya say this could be a pivotal moment.

Kayla Laserson of Centers for Disease Control and Prevention said, "A vaccine will be an amazing thing, you know, if it's successful. We'll see a big difference because malaria is still really a tremendous problem for children."

Rts,s has been developed by Glaxo-Smith-Kline and the path malaria vaccine initiative. An earlier phase two trial showed that it was around 50-per cent effective in young children. It works by bolstering antibodies that fight malaria as soon as it attacks.

Dr Louis Macareo, Director, Kombewa clinical trial center, said, "What we try to duplicate with the vaccine is to stimulate the body's immune system to produce similar antibodies."

Results from this trial will be available over the next year and a half. If the vaccine meets expectations, approval and licensing could follow as soon as 2015. In the meantime, all eyes are o­n the 15,000 small children in the trial who could be making history whether they like it or not.

Video

 

 

07/19/2011
(Source: CNN IBN Live July 18th2011)  

Announcement

LIBRARY
Book
Magazine
Document
Photos
Thesis
Documentary form
Research studies
PROFFESSIONAL SOFTWARE
Malaria forecast & management
Document management
Personel management
LEGAL DOCUMENTS
Law
Decision
Decree
Instruction
Circular
Official document
Reports
Others
SPECIFIED IMFORMATION
Malaria facts
Malaria epidemic
Petechial fever
HEALTH SERVICES
Hospital & medical centre
Drugstore
Surgery
Your doctor

Institue of Malariology Parastology and Entomology Quy Nhon
Address: 611B Nguyen Thai Hoc Str,. Quy Nhon City
Tel: (84) 056 846571 Fax: (84) 056 846755
• Designed by Quang Ich JSC